Literature DB >> 1321827

Inhibition of protein phosphatases blocks myogenesis by first altering MyoD binding activity.

S J Kim1, K Y Kim, S J Tapscott, T S Winokur, K Park, H Fujiki, H Weintraub, A B Roberts.   

Abstract

To examine the role of protein phosphatases in skeletal muscle differentiation, C2C12 myoblasts were treated with okadaic acid, a potent in vitro inhibitor of protein phosphatases 1 and 2A which regulate various cellular events in intact cells. We now show that okadaic acid treatment of the mouse myoblast C2C12 cell line reversibly altered the morphology of the cells and blocked differentiation. At a molecular level, it extinguished expression of the myogenic determination genes, MyoD1 and myogenin, but induced the expression of an inhibitor of differentiation, Id. Analysis of the MyoD1 promoter showed that inhibition of MyoD1 expression by okadaic acid occurs at the transcriptional level. These changes occur 10-20 h after okadaic acid treatment. However, within 1 h of treatment the ability of muscle extracts to support a specific MyoD-dependent gel mobility shift using a MyoD DNA binding site is lost. These data suggest that protein phosphatases play an important role during myogenic differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321827

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity.

Authors:  N Altiok; S Altiok; J P Changeux
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

2.  Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1.

Authors:  O Tournay; R Benezra
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

3.  Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination.

Authors:  S M Hollenberg; P F Cheng; H Weintraub
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

4.  Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators.

Authors:  S S Rao; C Chu; D S Kohtz
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  The kinase inhibitor iso-H7 stimulates rat satellite cell differentiation through a non-protein kinase C pathway by increasing myogenin expression level.

Authors:  C Lagord; M P Leibovitch; G Carpentier; S A Leibovitch; I Martelly
Journal:  Cell Biol Toxicol       Date:  1996-06       Impact factor: 6.691

6.  Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain.

Authors:  S Hardy; Y Kong; S F Konieczny
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

7.  Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle cells.

Authors:  J S Campbell; M P Wenderoth; S D Hauschka; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

8.  Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors.

Authors:  Y Kong; S E Johnson; E J Taparowsky; S F Konieczny
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

9.  Phosphatase orphan 1 inhibits myoblast proliferation and promotes myogenic differentiation.

Authors:  Ying Peng; Feng Yue; Jingjuan Chen; Wei Xia; Kuilong Huang; Gongshe Yang; Shihuan Kuang
Journal:  FASEB J       Date:  2020-11-02       Impact factor: 5.191

10.  Protein phosphatase activity is required for light-inducible gene expression in maize.

Authors:  J Sheen
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.